Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Lack of any Prognostic Role of Insulin-Like Growth Factor-1 Receptor in Non-Small Cell Lung Cancer

  • Dilli, Utku Donem (Department of Medical Oncology, Antalya Education and Research Hospital) ;
  • Yildırim, Mustafa (Department of Medical Oncology, Ministry of Health Batman Regional Government Hospital) ;
  • Suren, Dinc (Department of Pathology, Antalya Education and Research Hospital) ;
  • Alikanoglu, Arsenal (Department of Pathology, Antalya Education and Research Hospital) ;
  • Kaya, Vildan (Department of Radiation Oncology, Suleyman Demirel University School of Medicine) ;
  • Goktas, Sevil (Department of Medical Oncology, Antalya Education and Research Hospital) ;
  • Yildiz, Mustafa (Department of Medical Oncology, Antalya Education and Research Hospital) ;
  • Sezer, Cem (Department of Pathology, Antalya Education and Research Hospital) ;
  • Gunduz, Seyda (Department of Medical Oncology, Antalya Education and Research Hospital)
  • Published : 2014.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The purpose of this study is to determine whether the IGF1R expression has a prognostic role in non-small cell lung cancer. Materials and Methods: Forty-seven patients histopathologically diagnosed with small cell lung cancer upon bronchoscopic biopsy or resection materials were included in the study. IGF1R expression was examined via immunohistochemical methods. In samples, >10% staining were assessed as positive and ${\leq}10%$ as negative. Information about demographic datas and treatments was obtained by retrospective searches of patient files. Results: IGF1R expression was determined as positive in 38 (80.9%) and as negative in 9 (19.1%) patients. There was no significant relation between IGF1R expression and histological sub-type, local invasion, lymph node and metastasis status (p=0.842, p=0.437, 0.064, 0.447, respectively). There was also no correlation with IGF1R expression and survival (p=0.141). Conclusions: There are conflicting results between IGF1R and its prognostic effects in the various studies. It has been claimed in some studies it is not related to prognosis as in our study, and in some studies it has been claimed that it is a good prognostic factor whereas in some studies it has been claimed as being a factor for worse prognosis. We think that IGF1R expression in non-small cell lung carcinoma patients deserves further analysis, because of its potential prognostic and predictive roles.

Keywords

References

  1. Alexia C, Fallot G, Lasfer M, et al (2004). An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem Pharmacol, 68, 1003-15. https://doi.org/10.1016/j.bcp.2004.05.029
  2. Cappuzzo F, Tallini G, Finocchiaro G, et al (2010). Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients. Ann Oncol, 21, 562-7. https://doi.org/10.1093/annonc/mdp357
  3. Casa AJ, Dearth RK, Litzenburger BC, et al (2008). The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance. Front Biosci, 13, 3273-87.
  4. Chen HX, Sharon E. IGF-1R as an anti-cancer target--trials and tribulations. Chin J Cancer, 32, 242-52.
  5. Ding J, Tang J, Chen X, et al (2013). Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus. Asian Pac J Cancer Prev, 14, 5675-80. https://doi.org/10.7314/APJCP.2013.14.10.5675
  6. Dziadziuszko R, Merrick DT, Witta SE, et al (2010). Insulinlike growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. J Clin Oncol, 28, 2174-80. https://doi.org/10.1200/JCO.2009.24.6611
  7. Frasca F, Pandini G, Sciacca L, et al (2008). The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem, 114, 23-37. https://doi.org/10.1080/13813450801969715
  8. Goto Y, Sekine I, Tanioka M, et al (2012). Figitumumab combined with carboplatin and paclitaxel in treatment-naive Japanese patients with advanced non-small cell lung cancer. Invest New Drugs, 30, 1548-56. https://doi.org/10.1007/s10637-011-9715-4
  9. Gualberto A, Karp DD (2009). Development of the monoclonal antibody figitumumab, targeting the insulin-like growth factor-1 receptor, for the treatment of patients with nonsmall- cell lung cancer. Clin Lung Cancer, 10, 273-80. https://doi.org/10.3816/CLC.2009.n.038
  10. Karp DD, Paz-Ares LG, Novello S, et al (2009). Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic nonsmallcell lung cancer. J Clin Oncol, 27, 2516-22. https://doi.org/10.1200/JCO.2008.19.9331
  11. Kikuchi R, Sonobe M, Kobayashi M, et al (2012). Expression of IGF1R is associated with tumor differentiation and survival in patients with lung adenocarcinoma. Ann Surg Oncol, 19, 412-20. https://doi.org/10.1245/s10434-011-1878-x
  12. Kim JS, Kim ES, Liu D, et al (2012). Prognostic impact of insulin receptor expression on survival of patients with non-small cell lung cancer. Cancer, 118, 2454-65. https://doi.org/10.1002/cncr.26492
  13. Kim WY, Prudkin L, Feng L, Kim ES, et al (2012). EGFR and K-Ras Mutations and Resistance of Lung Cancer to IGF-1R Tyrosine Kinase Inhibitors. Cancer, 118, 3993-4003. https://doi.org/10.1002/cncr.26656
  14. Kulesza P, Ramchandran K, Patel JD (2011). Emerging concepts in the pathology and molecular biology of advanced nonsmall cell lung cancer. Am J Clin Pathol, 136, 228-38. https://doi.org/10.1309/AJCPO66OIRULFNLZ
  15. Lee CY, Jeon JH, Kim HJ, et al (2008). Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis. Korean J Intern Med, 23, 116-20. https://doi.org/10.3904/kjim.2008.23.3.116
  16. Li Q, You C, Liu L, et al (2013). Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R). Clin Neurosci, 20, 153-7. https://doi.org/10.1016/j.jocn.2012.04.014
  17. Luqman M, Javed MM, Daud S, et al (2014). Risk factors for lung cancer in the Pkistani population. Asian Pac J Cancer Prev, 15, 3035-9. https://doi.org/10.7314/APJCP.2014.15.7.3035
  18. Mandal SK, Singh TT, Sharma TD, et al (2013). Clinicopathology of lung cancer in a regional cancer center in Northeastern India. Asian Pac J Cancer Prev, 14, 7277-81. https://doi.org/10.7314/APJCP.2013.14.12.7277
  19. Merrick DT, Dziadziuszko R, Szostakiewicz B, et al (2007). High insulin-like growth factor 1 receptor (IGF1R) expression is associated with poor survival in surgically treated non-small cell lung cancer (NSCLC) patients. J Clin Oncol, 25, 181-7.
  20. Monti S, Proietti-Pannunzi L, Sciarra A, et al (2007). The IGF axis in prostate cancer. Curr Pharm Des, 13, 719-27. https://doi.org/10.2174/138161207780249128
  21. O'Brien MF, Watson RW, Fitzpatrick JM (2001). Insulin-like growth factor I and prostate cancer. Urology, 58, 1-7.
  22. Pollak M (2000). Insulin like growth factor physiology and cancer risk. Eur J Cancer, 36, 1224-8. https://doi.org/10.1016/S0959-8049(00)00102-7
  23. Resnik JL, Reichart DB, Huey K, et al (1998). Elevated Insuline- Like growth factor I receptor autophosphorilation and kinase activity in human breast cancer. Cancer Res, 58, 1159-64.
  24. Samani AA, Yakar S, LeRoith D, et al (2007). The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev, 28, 20-47. https://doi.org/10.1210/er.2006-0001
  25. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
  26. Sun Y, Zheng S, Torossian A, et al (2012). Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells. Int J Radiat Oncol Biol Phys, 82, 563-72. https://doi.org/10.1016/j.ijrobp.2011.06.1999
  27. Suzuki S, Kojima M, Tokudome S, et al (2009). Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study. Asian Pac J Cancer Prev, 10 ,45-9.
  28. Tantraworasin A, Lertprasertsuke N, Kongkarnka S, et al (2014). Retrospective Study of ALK rearrangement and clinicopathological implications in completely resected non- small cell lung cancer patients in northern Thailand: role of screening with D5F3 antibodies. Asian Pac J Cancer Prev, 15, 3057-63. https://doi.org/10.7314/APJCP.2014.15.7.3057
  29. Tong D Y, Wen X Q, Jin Y, et al (2010). Changes of androgen receptor and insulin-like growth factor-1 in LNCaP prostate cancer cells treated with sex hormones and lutamide. Asian Pac J Cancer Prev, 11, 1805-9.
  30. Unal OU, Oztop I, Calibasi G, et al (2013). Relationship between epidermal growth factor receptor gene mutations and clinicopathological features in patients with non-small cell lung cancer in western Turkey. Asian Pac J Cancer Prev, 14, 3705-9. https://doi.org/10.7314/APJCP.2013.14.6.3705
  31. Vincent EE, Elder DJ, Curwen J, et al (2013). Targeting nonsmall cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor. PLoS ONE, 8, 66963. https://doi.org/10.1371/journal.pone.0066963
  32. Yamamoto T, Oshima T, Yoshihara K, et al (2012). Clinical significance of immunohistochemical expression of insulinlike growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer. Exp Ther Med, 3, 797-802.
  33. Yildirim M, M Yildiz, S Goktas, et al (2013). Comparison of the use of platinum-based combination in the first and second line treatment of non-small cell lung cancer. J Clin Anal Med, 4, 390-3. https://doi.org/10.4328/JCAM.1111
  34. Xiong ZP, Huang F, Lu MH (2012). Association between insulin-like growth factor-2 expression and prognosis after transcatheter arterial chemoembolization and octreotide in patients with hepatocellar carcinoma. Asian Pac J Cancer Prev, 13, 3191-4. https://doi.org/10.7314/APJCP.2012.13.7.3191